Home Sectors Healthcare Current Change: Hill-Rom Inc (NYSE: HRC)

Current Change: Hill-Rom Inc (NYSE: HRC)


Hill-Rom Inc is in the healthcare sector and is in the medical instruments and equipment industry. The company CEO is John P. Groetelaars. Hill-Rom Inc is engaged in selling and renting patient support and near-patient technologies and services, and health information technology solutions in the U.S and Canada.

Previous Intraday Trading Performance:

The HRC stock showed a previous change of 3.66% with an open at 97.64 and a close of 100.43. It reached an intraday high of 100.97 and a low of 97.43.

PR Newswire:  Hill-Rom Unveils New Corporate Logo And Global Brand Identity


The stock has a market cap of $6.7b with 66.8m shares outstanding, of which the float is 65.4m shares. Trading volume reached 497,676 shares compared to its average volume of 509,467 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Hill-Rom Inc shares returned 5.18% and in the past 30 trading days it returned 4.66%. Over three months, it changed -4.79%. In one year it has changed 8.75% and within that year its 52-week high was 108.68 and its 52-week low was 81.82. HRC stock is 22.75% above its 52 Week Low.

Our calculations show a 200 day moving average of 96.36 and a 50 day moving average of 100.43. Currently HRC stock is trading 4.23% above its 200 day moving average and may be a good opportunity to buy.

PR Newswire:  Hill-Rom Unveils New Corporate Logo And Global Brand Identity


The last annual fiscal EPS for the company was reported at 3.73 that ended on 30th of September 2018, which according to the previous close, that is a PE of 26.92. Based on 5 analyst estimates, the consensus EPS for the next quarter is 0.98. The TTM EPS is 4.85, which comes to a TTM PE of 20.71. Historically, the PE high was 75.80 and the PE low was 20.10. If the stock reached its PE low, that would represent a price of 97.47, which is a decrease of -2.95%.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 04/26/2019): 0.74
4thQtr of 2018 (Reported on 01/25/2019): 0.62
3rdQtr of 2018 (Reported on 11/02/2018): 1.33
2ndQtr of 2018 (Reported on 07/27/2018): 0.67
1stQtr of 2018 (Reported on 04/27/2018): 0.42

The dividend per share is currently 0.84, which is a dividend yield of 0.84%. Also, the payout ratio is 17.32%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 96.58, which means it may be overvalued by -3.98%.

Indicators to Watch:

Short-interest was 1,290,923, which was 1.93% of shares outstanding. The short-interest ratio or days-to-cover ratio was 2.73. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 0.90.

Business Wire:  Medical Properties Trust Acquires 46% Interest in $900 Million Portfolio of Premier Swiss Hospitals

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 15.28%, return on assets is 5.37%, profit margin is 7.95%, price-to-sales is 2.26 and price-to-book is 4.05.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 3  :Past Performance Score
 3  :Financial Strength Score
 1  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.